BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Operating income 2018–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) annual operating income history from SEC filings — each fiscal year as reported.
$12.5MFY2025 · since FY2018: -$8.9M → $12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.5M | +115.9% |
| FY2024 | -$78.8M | +8.9% |
| FY2023 | -$86.5M | +6.9% |
| FY2022 | -$92.8M | +26.8% |
| FY2021 | -$126.9M | -82.4% |
| FY2020 | -$69.6M | -137.2% |
| FY2019 | -$29.3M | -229.4% |
| FY2018 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BDTX financial trends
BDTX RevenueBDTX Net incomeBDTX Net marginBDTX Gross profitBDTX Gross marginBDTX Operating marginBDTX Operating cash flowBDTX Free cash flowBDTX Capital expendituresBDTX Return on equityBDTX Stock buybacksBDTX Dividends paidBDTX Total assetsBDTX Total liabilitiesBDTX Shareholders’ equityBDTX overview →